Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
– Sell
-10,000
Closed -$36K – 886
2017
Q2
$36K Hold
10,000
– – ﹤0.01% 781
2017
Q1
$30K Hold
10,000
– – ﹤0.01% 768
2016
Q4
$35K Hold
10,000
– – ﹤0.01% 725
2016
Q3
$30K Hold
10,000
– – ﹤0.01% 733
2016
Q2
$28K Hold
10,000
– – ﹤0.01% 687
2016
Q1
$24K Hold
10,000
– – ﹤0.01% 687
2015
Q4
$20K Hold
10,000
– – ﹤0.01% 686
2015
Q3
$13K Hold
10,000
– – ﹤0.01% 661
2015
Q2
$24K Hold
10,000
– – ﹤0.01% 697
2015
Q1
$31K Hold
10,000
– – ﹤0.01% 742
2014
Q4
$23K Buy
+10,000
New +$26K ﹤0.01% 710

Other funds holding ARTX

Sigma Planning's ARTX Position: Q3 2017 in Review

Sigma Planning sold out of Arotech (ARTX) in Q3 2017, closing a stake of 10,000 shares — an estimated $36K sold.

Sigma Planning first reported a position in ARTX in Q4 2014 and held it in 11 quarters. The position peaked at $36K in Q2 2017. 49 funds tracked by Wall St. Rank hold ARTX as of Q3 2017.

  • Sigma Planning reported no remaining Arotech position as of Q3 2017 after selling out during the quarter.
  • Sigma Planning sold 10,000 Arotech shares in Q3 2017, an estimated $36K.
  • Sigma Planning first reported a position in Arotech in Q4 2014 and held it in 11 quarters.
  • Sigma Planning's Arotech position peaked at $36K in Q2 2017.
  • 49 funds tracked by Wall St. Rank held Arotech as of Q3 2017.

Based on Sigma Planning's 13F filing for Q3 2017, filed 6 Nov 2017.